Falcorab-DSR Capsule is a combination medication containing Domperidone 30mg and Rabeprazole 20mg, designed to effectively manage gastrointestinal disorders such as acid reflux, gastroesophageal reflux disease (GERD), and dyspepsia. Rabeprazole, a proton pump inhibitor, works by reducing the production of stomach acid, thereby alleviating symptoms like heartburn, acid regurgitation, and stomach pain. Domperidone, a prokinetic agent, enhances gastrointestinal motility and accelerates gastric emptying, which helps in reducing nausea, vomiting, and bloating often associated with delayed gastric emptying or gastroparesis. The synergistic action of these two components provides comprehensive relief from acid-related discomfort and improves digestive function. Falcorab-DSR is typically prescribed for short-term use under medical supervision and should be taken as directed to maximize efficacy and minimize potential side effects. Common side effects may include dry mouth, headache, or mild gastrointestinal disturbances, but serious adverse reactions are rare when used appropriately. Patients with known allergies to either component, severe liver disease, or certain cardiac conditions should consult their healthcare provider before using this medication. Overall, Falcorab-DSR Capsule offers an effective therapeutic option for individuals suffering from acid-related gastrointestinal conditions requiring both acid suppression and enhanced motility.